On the Inflammation Theory of Cancer

Alain L Fymat
Additional contact information
Alain L Fymat: International Institute of Medicine and Science, USA

Cancer Therapy & Oncology International Journal, 2017, vol. 8, issue 3, 59-65

Abstract: A recent clinical trial on humans (CANTOS) aimed to test inflammation, one of the two major theories for cardiovascular diseases, the other theory being concerned with lipids. However, somewhat surprisingly, the trial provided some support for the inflammation theory of cancer and this result may overshadow the trial’s original aim. However, inflammation has long been linked to cancer. As a preface to the link between inflammation and cancer, I first review the trial and summarize its results within the context of secondary prevention and mechanism pathways. With different doses against placebo, the drug tested in the trial was Canakinumab, a monoclonal antibody that targets Interleukin-1β. From a personalized medicine’s perspective, the trial and its results point to the future of secondary prevention as the identification of which mechanistic pathway would be most beneficial for a given patient. From this viewpoint, inflammation today is very much analogous to the identification of cholesterol 30 years ago. We now need to distinguish those heart disease patients who have “residual cholesterol risk†from those who have “residual inflammatory risk†, or both. These two groups will require different, perhaps also simultaneous, interventions.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555740.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555740.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:8:y:2017:i:3:p:59-65

DOI: 10.19080/CTOIJ.2017.08.555740

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().